MedTrace Logo

Functional Proprioceptive Stimulation and Continuous Passive Motion Rehabilitation Interventions After Anterior Cruciate Ligament Reconstruction

NCT07553013 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2026-04-27

No results posted yet for this study

Summary

The goal of this trial is to test if functional proprioceptive stimulations combined with continuous passive movement is more efficient than continuous passive movement alone to recover knee joint mobility after anterior cruciate ligament reconstruction in adults. It will also learn about the influence of functional proprioceptive stimulations on pain and pain medication. The main questions it aims to answer are:

* Does functional proprioceptive stimulations combined with continuous passive movement increase knee joint mobility more than continuous passive movement alone?
* Does functional proprioceptive stimulations combined with continuous passive movement reduce perceived pain and pain medication use more than continuous passive movement alone? Researchers will compare functional proprioceptive stimulations combined with continuous passive movement to continuous passive movement alone to see if functional proprioceptive stimulations combined with continuous passive movement is more efficient than continuous passive movement alone.

Participants will:

* Follow a supervised rehabilitation intervention comprising functional proprioceptive stimulations combined with continuous passive movement or continuous passive movement alone during five days a week for 2 weeks
* Attend the clinic five days a week for 2 weeks for rehabilitation, checkups and assessments

Conditions

  • Anterior Cruciate Ligament Reconstruction Rehabilitation

Interventions

DEVICE

functional proprioceptive stimulations combined with continuous passive movement

5 days a week for 2 weeks

DEVICE

continuous passive movement

5 days a week for 2 weeks

Sponsors & Collaborators

  • Universite Cote d'Azur

    lead OTHER

Principal Investigators

  • Serge S Colson, Professor · Universite Cote d'Azur

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-16
Primary Completion
2025-10-24
Completion
2025-10-24

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07553013 on ClinicalTrials.gov